Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omega-3 Fatty Acid Treatment of 174 Patients With Mild to Moderate Alzheimer's Disease (OmegAD): a Randomized Double-blind Trial

NCT00211159 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT00211159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00211159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omega-3 Fatty Acid Treatment of 174 Patients With Mild to Moderate Alzheimer's Disease (OmegAD): a Randomized Double-blind Trial
Lead sponsor
Karolinska University Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2000
Completion date
Not reported
Enrollment
204
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease